Case For Sight will hold its annual distinguished lecture, featuring Donald L. Budenz from the University of North Carolina at Chapel Hill. He will discuss glaucoma, the leading cause of irreversible ...

Christopher Girkin, M.D., from the UAB Department of Ophthalmology and Visual Sciences, has been chosen as the American Glaucoma Society-Clinician Scientist Lecture for their annual meeting in 2025.

Most patients do well on topical therapy, but innovation in IOP-lowering drops remains essential. One might ask why topical eye drop medications remain the mainstay of glaucoma therapy in the US and ...

Ocular surface disease (OSD) is a prevalent yet frequently underrecognized challenge in the management of glaucoma. A ...

SAN FRANCISCO, Feb. 3, 2025 /PRNewswire/ — Glaucoma 360 is Glaucoma Research Foundation’s signature three-day series of events, with a festive Gala on day one, an innovation incubator on day two, and ...

Please provide your email address to receive an email when new articles are posted on . LAS VEGAS —Finding treatment options for glaucoma beyond IOP lowering may be the future course toward preventing ...

UC Irvine Chancellor Michael Drake will discuss the healthcare challenges facing minorities and low-income people Thursday as part of the Allen Lecture Series organized by the Newkirk Center for ...